U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent License Agreement. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 19 contracts
Samples: Patent License Agreement (Aileron Therapeutics Inc), Patent License Agreement (TFF Pharmaceuticals, Inc.), License Agreement (Icosavax, Inc.)
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent & Technology License Agreement. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 14 contracts
Samples: Technology License Agreement, American Boarding Co, American Boarding Co
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent License Agreement. Exhibit A. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 10 contracts
Samples: Technology License Agreement (Aileron Therapeutics Inc), Patent and Technology License Agreement (MAIA Biotechnology, Inc.), Patent and Technology License Agreement (MAIA Biotechnology, Inc.)
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent & Technology License Agreement. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.. Exhibit 10.4
Appears in 3 contracts
Samples: American Boarding Co, Microlin Bio, Inc., Microlin Bio, Inc.
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent License Agreement. Exhibit A. Licensee will inform Licensor MD Xxxxxxxx in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 3 contracts
Samples: Technology License Agreement, Technology License Agreement, Technology License Agreement
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent License Agreement. EXHIBIT A. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 2 contracts
Samples: Technology License Agreement (LogicBio Therapeutics, Inc.), Technology License Agreement (LogicBio Therapeutics, Inc.)
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent License Agreement. Exhibit A. Licensee will inform Licensor LLU in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 2 contracts
Samples: Patent & Technology License Agreement (ADiTx Therapeutics, Inc.), Patent & Technology License Agreement (ADiTx Therapeutics, Inc.)
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent License Agreement. Licensee will inform Licensee: Aeglea BioTherapeutics, Inc. CONFIDENTIALExclusive PLA The University of Texas at Austin Page 13 Agreement No. PM1401501 US 4915892v.1 Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 1 contract
Samples: Patent License Agreement (Aeglea BioTherapeutics, Inc.)
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as 21818479.1 238213-10001 12 set forth in Section 1 of the Patent License Agreement. Exhibit A. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.
Appears in 1 contract
Samples: Patent and Technology License Agreement (MAIA Biotechnology, Inc.)
U.S. Patent and Trademark Office Entity Size Status. Licensee represents that as of the Effective Date the entity size status of Licensee in accordance with the regulations of the U.S. Patent and Trademark Office is as set forth in Section 1 of the Patent & Technology License Agreement. Licensee will inform Licensor in writing on a timely basis of any change in its U.S. Patent and Trademark Office entity size status.. Licensee: Blue Water Vaccines, Inc.OTC Exclusive License (Life Sciences) CONFIDENTIAL
Appears in 1 contract
Samples: Technology License Agreement (Blue Water Biotech, Inc.)
